January 14, 2004Open Access
View Full PaperA Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Key Points
- This study aims to evaluate the effectiveness of a polymer-based, paclitaxel-eluting stent compared to bare-metal stents in reducing restenosis.
- Compared polymer-based paclitaxel-eluting stents with bare-metal stents
- Followed patients for nine months
- Analyzed rates of clinical and angiographic restenosis.
- The paclitaxel-eluting stent significantly reduced clinical restenosis rates compared to bare-metal stents.
- Angiographic restenosis rates were markedly lower with the polymer-based stent at nine months.
Abstract
As compared with bare-metal stents, the slow-release, polymer-based, paclitaxel-eluting stent is safe and markedly reduces the rates of clinical and angiographic restenosis at nine months.